Literature DB >> 30056178

Evaluating the broad-spectrum efficacy of the acetylcholinesterase oximes reactivators MMB4 DMS, HLö-7 DMS, and 2-PAM Cl against phorate oxon, sarin, and VX in the Hartley guinea pig.

Christina M Wilhelm1, Thomas H Snider2, Michael C Babin3, Gennady E Platoff4, David A Jett5, David T Yeung6.   

Abstract

Organophosphorus (OP) compounds, including pesticides and chemical warfare nerve agents (CWNA), are threats to the general population as possible weapons of terrorism or by accidental exposure whether through inadvertent release from manufacturing facilities or during transport. To mitigate the toxicities posed by these threats, a therapeutic regimen that is quick-acting and efficacious against a broad spectrum of OPs is highly desired. The work described herein sought to assess the protective ratio (PR), median effective doses (ED50), and therapeutic index (TI = oxime 24-h LD50/oxime ED50) of MMB4 DMS, HLö-7 DMS, and 2-PAM Cl against the OPs sarin (GB), VX, and phorate-oxon (PHO). All OPs are representative of the broader classes of G and V chemical warfare nerve agents and persistent pesticides. MMB4 DMS and HLö-7 DMS were previously identified as comparative efficacy leads warranting further evaluations. 2-PAM Cl is the U.S. FDA-approved standard-of-care oxime therapy for OP intoxication. Briefly, PRs were determined in male guinea pigs by varying the subcutaneously (SC) delivered OP dose followed then by therapy with fixed levels of the oxime and atropine (0.4 mg/kg; administered intramuscularly [IM]). ED50s were determined using a similar approach except the OP dose was held constant at twice the median lethal dose (2 × LD50) while the oxime treatment levels were varied. The ED50 information was then used to calculate the TI for each OP/oxime combination. Both MMB4 DMS and HLö-7 DMS provided significant protection, i.e., higher PR against GB, VX, and PHO when compared to atropine controls, but significance was not readily demonstrated across the board when compared against 2-PAM Cl. The ED50 values of MMB4 DMS was consistently lower than that of the other oximes against all three OPs. Furthermore, based on those ED50s, the TI trend of the various oximes against both GB and VX was MMB4 DMS > HLö-7 DMS > 2-PAM Cl, while against PHO, MMB4 DMS > 2-PAM Cl > HLö-7 DMS.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ED(50); HED; HLö-7 DMS; MMB4 DMS; Phorate-oxon; Protective ratio

Mesh:

Substances:

Year:  2018        PMID: 30056178      PMCID: PMC6153028          DOI: 10.1016/j.neuro.2018.07.014

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  21 in total

Review 1.  Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment.

Authors:  Jirí Bajgar
Journal:  Adv Clin Chem       Date:  2004       Impact factor: 5.394

Review 2.  Chemical warfare agents: II. Nerve agents.

Authors:  F R Sidell; J Borak
Journal:  Ann Emerg Med       Date:  1992-07       Impact factor: 5.721

3.  Syrian gas attack reinforces need for better anti-sarin drugs.

Authors:  Elie Dolgin
Journal:  Nat Med       Date:  2013-10       Impact factor: 53.440

4.  Comparison of human and guinea pig acetylcholinesterase sequences and rates of oxime-assisted reactivation.

Authors:  C Linn Cadieux; Clarence A Broomfield; Melanie G Kirkpatrick; Meghan E Kazanski; David E Lenz; Douglas M Cerasoli
Journal:  Chem Biol Interact       Date:  2010-04-28       Impact factor: 5.192

5.  Efficacy of Recommended Prehospital Human Equivalent Doses of Atropine and Pralidoxime Against the Toxic Effects of Carbamate Poisoning in the Hartley Guinea Pig.

Authors:  Matthew K Brittain; Kevin G McGarry; Robert A Moyer; Michael C Babin; David A Jett; Gennady E Platoff; David T Yeung
Journal:  Int J Toxicol       Date:  2016-04-21       Impact factor: 2.032

6.  A comprehensive evaluation of the efficacy of leading oxime therapies in guinea pigs exposed to organophosphorus chemical warfare agents or pesticides.

Authors:  Christina M Wilhelm; Thomas H Snider; Michael C Babin; David A Jett; Gennady E Platoff; David T Yeung
Journal:  Toxicol Appl Pharmacol       Date:  2014-10-31       Impact factor: 4.219

7.  Catalytic detoxification of nerve agent and pesticide organophosphates by butyrylcholinesterase assisted with non-pyridinium oximes.

Authors:  Zoran Radić; Trevor Dale; Zrinka Kovarik; Suzana Berend; Edzna Garcia; Limin Zhang; Gabriel Amitai; Carol Green; Božica Radić; Brendan M Duggan; Dariush Ajami; Julius Rebek; Palmer Taylor
Journal:  Biochem J       Date:  2013-02-15       Impact factor: 3.857

8.  Species difference of esterase expression and hydrolase activity in plasma.

Authors:  Fatma Goksin Bahar; Kayoko Ohura; Takuo Ogihara; Teruko Imai
Journal:  J Pharm Sci       Date:  2012-07-25       Impact factor: 3.534

9.  Investigation of the reactivation kinetics of a large series of bispyridinium oximes with organophosphate-inhibited human acetylcholinesterase.

Authors:  Michael Winter; Timo Wille; Kamil Musilek; Kamil Kuca; Horst Thiermann; Franz Worek
Journal:  Toxicol Lett       Date:  2015-07-22       Impact factor: 4.372

10.  Novel nonquaternary reactivators showing reactivation efficiency for soman-inhibited human acetylcholinesterase.

Authors:  Zhao Wei; Yan-Qin Liu; Yong-An Wang; Wan-Hua Li; Xin-Bo Zhou; Jian Zhao; Chun-Qian Huang; Xing-Zhou Li; Jia Liu; Zhi-Bing Zheng; Song Li
Journal:  Toxicol Lett       Date:  2016-01-22       Impact factor: 4.372

View more
  1 in total

1.  Positron emission tomography evaluation of oxime countermeasures in live rats using the tracer O-(2-[18 F]fluoroethyl)-O-(p-nitrophenyl)methylphosphonate [18 F]-VXS.

Authors:  Thomas R Hayes; Joseph E Blecha; Chih-Kai Chao; Tony L Huynh; Henry F VanBrocklin; Kurt R Zinn; Palmer W Taylor; John M Gerdes; Charles M Thompson
Journal:  Ann N Y Acad Sci       Date:  2020-05-20       Impact factor: 5.691

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.